Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
BufferGel and PRO 2000/5: Vaginal Gels to Prevent HIV Infection in Women
This study is ongoing, but not recruiting participants.
Study NCT00074425.   Last updated on September 11, 2008.
Information provided by National Institute of Allergy and Infectious Diseases (NIAID)
Please refer to this study by its ClinicalTrials.gov identifier: NCT00074425
Locations
United States, Pennsylvania
University of Pennsylvania
Philadelphia, Pennsylvania, United States
Malawi
Malawi College of Medicine, Queen Elizabeth Central Hospital
Blantyre, Malawi
South Africa
Medical Research Council - Hlabisa
Hlabisa, South Africa
R.K. Khan Hospital
Chatsworth, South Africa
Tanzania
Kilimanjaro Christian Medical Center
Moshi, Tanzania
Zambia
Kamwala Clinic
Lusaka, Zambia
Zimbabwe
Zimbabwe National Family Planning Council
Harare, Zimbabwe, 263
Seke South Clinic
Harare, Zimbabwe, 263
Sponsors and Collaborators
National Institute of Allergy and Infectious Diseases (NIAID)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
National Institute on Drug Abuse (NIDA)
National Institute of Mental Health (NIMH)
HIV Prevention Trials Network
Investigators
Study Chair: Salim Abdool Karim, MBChB, PhD University of KwaZulu-Natal, Centre for the AIDS Programme of Research in South Africa, Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine
Study Chair: Irving Hoffman, PA, MPH School of Medicine, University of North Carolina
Study Chair: Lisa Maslankowski, MD University of Pennsylvania
Study Chair: Groesbeck Parham, MD Centre for Infectious Disease Research in Zambia
Study Chair: Nancy Padian, PhD Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco; AIDS Research Institute
Study Chair: Gita Ramjee, PhD Medical Research Council, HIV Prevention Research Unit
Study Chair: Taha Taha, MD Johns Hopkins Bloomberg School of Public Health